<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">scbmt</journal-id><journal-title-group><journal-title xml:lang="ru">БИОМЕДИЦИНА</journal-title><trans-title-group xml:lang="en"><trans-title>Journal Biomed</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2074-5982</issn><issn pub-type="epub">2713-0428</issn><publisher><publisher-name>Scientific center of biomedical technologies of Federal Medical and Biological Agency</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.33647/2713-0428-17-3E-133-138</article-id><article-id custom-type="elpub" pub-id-type="custom">scbmt-1328</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ДОКЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯ В БИОМЕДИЦИНЕ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>NON-CLINICAL RESEARCH IN BIOMEDICINE</subject></subj-group></article-categories><title-group><article-title>Изучение адъювантных свойств наночастиц из экстракта бересты при иммунизации мини свиней светлогорской популяции</article-title><trans-title-group xml:lang="en"><trans-title>Investigation of the adjuvant properties of nanoparticles from a birch bark extract used for immunization of mini pigs of the Svetlogorsk population</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Берзина</surname><given-names>А. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Berzina</surname><given-names>A. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.б.н.,</p><p>119034, Москва, Кропоткинский пер., 23</p></bio><bio xml:lang="en"><p>Cand. Sci. (Biol.),</p><p>119034, Moscow, Kropotkinskiy lane, 23</p></bio><email xlink:type="simple">berzina07@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Станкова</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Stankova</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.б.н.,</p><p>143442, Московская обл., Красногорский р-н, п. Светлые горы, 1</p></bio><bio xml:lang="en"><p>143442, Moscow Region, Krasnogorsk District, Svetlye Gory Village, 1</p></bio><email xlink:type="simple">sinayva@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Каплун</surname><given-names>А. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Kaplun</surname><given-names>A. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.х.н., проф.,</p><p>119454, Москва, просп. Вернадского, 78</p></bio><bio xml:lang="en"><p>119454, Moscow, Vernadskogo Avenue, 78</p></bio><email xlink:type="simple">alex.kaplun@mail.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Буркова</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Burkova</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>119454, Москва, просп. Вернадского, 78</p></bio><bio xml:lang="en"><p>119454, Moscow, Vernadskogo Avenue, 78</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гамалея</surname><given-names>Н. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Gamaleya</surname><given-names>N. B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., проф.,</p><p>119034, Москва, Кропоткинский пер., 23</p></bio><bio xml:lang="en"><p>119034, Moscow, Kropotkinskiy lane, 23</p></bio><email xlink:type="simple">natgam@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Национальный научный центр наркологии — филиал ФГБУ «Национальный медицинский научно-исследовательский центр психиатрии и наркологии им. В.П. Сербского» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>National Scientific Center of Narcology — Branch of the National Medical Research Center of Psychiatry and Narcology named after V.P. Serbskiy of the Ministry of Health Care of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБУН «Научный центр биомедицинских технологий ФМБА России»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Scientific Center of Biomedical Technologies of the Federal Medical and Biological Agency of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГБОУ ВО «МИРЭА — Российский технологический университет»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>MIREA — Russian Technological University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>25</day><month>10</month><year>2021</year></pub-date><volume>17</volume><issue>3E</issue><fpage>133</fpage><lpage>138</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Берзина А.Г., Станкова Н.В., Каплун А.П., Буркова А.А., Гамалея Н.Б., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Берзина А.Г., Станкова Н.В., Каплун А.П., Буркова А.А., Гамалея Н.Б.</copyright-holder><copyright-holder xml:lang="en">Berzina A.G., Stankova N.V., Kaplun A.P., Burkova A.A., Gamaleya N.B.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.scbmt.ru/jour/article/view/1328">https://journal.scbmt.ru/jour/article/view/1328</self-uri><abstract><p>Проведено исследование по изучению адъювантных свойств наночастиц, выделенных из сухого экстракта бересты. Эксперименты по иммунизации проводились на мини-свиньях светлогорской популяции — биомодели человека. Животные получали две подкожные инъекции антигена в дозе 0,1 мг/кг с интервалом 14 дней. Добавление в пробы иммуногена водной суспензии наночастиц до конечной концентрации 0,5 мг/мл приводило к усилению иммунного ответа. Побочных эффектов не наблюдалось. Титры антител в сыворотках крови на 60-й и 90-й день от начала иммунизации были сопоставимы с теми, что были получены в аналогичных условиях с применением адъюванта Фрейнда (1:4000). </p></abstract><trans-abstract xml:lang="en"><p>The adjuvant properties of nanoparticles derived from a dry birch bark extract were studied. Immunization experiments were carried out on mini pigs of the Svetlogorsk population, a human biomodel. Animals received two subcutaneous injections of the antigen at a dose of 0.1 mg/kg with an interval of 14 days. The addition of an aqueous suspension of nanoparticles to the immunogen samples up to a final concentration of 0.5 mg/ml led to an increase in the immune response. No side effects were observed. The antibody titers in blood sera on the 60th and 90th days from the start of immunization were comparable to those obtained under similar conditions using Freund’s adjuvant (1:4000). </p></trans-abstract><kwd-group xml:lang="ru"><kwd>адъюванты</kwd><kwd>бетулин</kwd><kwd>иммунный ответ</kwd><kwd>мини-свиньи</kwd><kwd>наночастицы</kwd></kwd-group><kwd-group xml:lang="en"><kwd>adjuvants</kwd><kwd>betulin</kwd><kwd>immune response</kwd><kwd>mini pigs</kwd><kwd>nanoparticles</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Берзина А.Г., Станкова Н.В., Ульянова Л.И., Гамалея Н.Б., Капанадзе Г.Д. Использование мини-свиней светлогорской популяции в качестве биомодели для изучения иммунного ответа на введение иммуноглобулина G лошади. Биомедицина. 2016(4):47–53.</mixed-citation><mixed-citation xml:lang="en">Berzina A.G., Stankova N.V., Ul’yanova L.I., Gamaleya N.B., Kapanadze G.D. Ispol’zovanie mini-svinej svetlogorskoj populjacii v kachestve biomodeli dlja izuchenija immunnogo otveta na vvedenie immunoglobulina G loshadi [Svetlogorsk mini-pigs as a biomodel for studying the immune response of the horse immunoglobulin G]. Biomeditsina [Journal Biomed]. 2016(4):47– 53. (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Гамалея Н.Б., Берзина А.Г., Шестаков К.А., Капанадзе Г.Д., Ревякин А.О., Фокин Ю.В. Иммуноген для лечения и профилактики зависимости от опиатов. Патент РФ № 2548802. 2015.</mixed-citation><mixed-citation xml:lang="en">Gamaleya N.B., Berzina A.G., Shestakov K.A., Kapanadze G.D., Revyakin A.O., Fokin Yu.V. Immunogen dlja lechenija i profilaktiki zavisimosti ot opiatov [Immunogen for the treatment and prevention of opiate dependence]. Patent N 2548802 of the Russian Federation. 2015. (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Каплун А.П., Безруков Д.А., Попенко В.И., Швец В.И. Сферические аморфные наночастицы из тритерпеноидов бересты — новый тип субмикронных средств для доставки лекарственных субстанций. Биофармацевтический журнал. 2011;3(2):28–40.</mixed-citation><mixed-citation xml:lang="en">Kaplun A.P., Bezrukov D.A., Popenko V.I., Shvets V.I. Sfericheskie amorfnye nanochasticy iz triterpenoidov beresty — novyj tip submikronnyh sredstv dlja dostavki lekarstvennyh substancij [Spherical amorphous nanoparticles from birch bark triterpenoids as a new type of submicron delivery vehicle of medicinal substances]. Biopharmaceutical journal. 2011;3(2):28–40. (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Красильников И.В., Николаева А.М., Иванов А.В. Способ получения адъюванта для вирусных вакцин. Патент РФ № 2545714. 2015.</mixed-citation><mixed-citation xml:lang="en">Krasil’nikov I.V., Nikolaeva A.M., Ivanov A.V. Sposob poluchenija ad’’juvanta dlja virusnyh vakcin [A method of obtaining an adjuvant for viral vaccines]. Patent N 2545714 of the Russian Federation. 2015. (In Russian).</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
